44 studies found for:    "Chromosomal triplication"
Show Display Options
Rank Status Study
1 Recruiting Non-Invasive Chromosomal Evaluation of Trisomy Study
Conditions: Fetal Aneuploidy;   Trisomy 21;   Trisomy 18;   Trisomy 13;   Down Syndrome
Intervention:
2 Recruiting Study of the Efficacy of New Non-invasive Prenatal Tests for Screening for Fetal Trisomies Using Maternal Blood
Conditions: Trisomy 21;   Trisomy 18;   Trisomy 13
Interventions: Other: Integrated prenatal screening for Down's syndrome;   Other: Serum QUAD Assay for aneuploidy screening;   Other: Targeted NIPT assay using ccfDNA in maternal blood;   Other: Un-targeted NIPT assay using ccfDNA in maternal blood;   Other: Harmony™ Test (Ariosa Diagnostics)
3 Recruiting Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Conditions: Trisomy 13;   Trisomy 18;   Trisomy 21;   Aneuploidy
Intervention: Procedure: Blood Draw
4 Recruiting Development of Non-invasive Prenatal Test for Microdeletion/Duplication and Other Genetic Syndromes Based on Fetal DNA Isolated From Maternal Blood
Conditions: Microdeletion Syndromes;   Trisomy 21;   Trisomy 18;   Trisomy 13;   Sex Chromosome Abnormalities
Intervention:
5 Recruiting Prenatal Screening for Down Syndrome With DNAFirst
Conditions: Trisomy 21;   Trisomy 18;   Trisomy 13;   Monosomy X
Intervention:
6 Recruiting Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
Conditions: Trisomy 21;   Trisomy 18;   Trisomy 13;   Sex Chromosome Abnormalities;   Microdeletion Syndromes
Intervention:
7 Completed Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Conditions: Down Syndrome (Trisomy 21);   Edwards Syndrome (Trisomy 18);   Patau Syndrome (Trisomy 13);   Turner Syndrome
Intervention:
8 Unknown  Non-Invasive Determination of Fetal Chromosome Abnormalities
Conditions: Down Syndrome (Trisomy 21);   Edward's Syndrome (Trisomy 18);   Patau Syndrome (Trisomy 13);   Klinefelter Syndrome (47, XXY);   and Other Chromosome;   Abnormalities.
Intervention:
9 Completed Non-invasive Chromosomal Examination of Trisomy Study
Condition: Trisomy 21
Intervention:
10 Completed Trisomy of Chromosome 21 Diagnosis by High Output Sequencing
Condition: Trisomy 21 - Translocation
Intervention:
11 Completed Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)
Conditions: Primary Sclerosing Cholangitis;   Trisomy 7;   Cholangiocarcinoma;   Chemoprevention
Intervention: Drug: Erlotinib (Tarceva)
12 Recruiting Non Invasive Prenatal Diagnosis of Trisomy 21 by Genetic Analysis of Circulating Fetal Cells
Condition: Trisomy 21
Intervention: Other: sample blood
13 Recruiting Efficacy and Safety of Oral Rigosertib in Transfusion-dependent, Low or Int-1 or Trisomy 8 Int-2 Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndrome;   MDS;   Trisomy 8
Intervention: Drug: rigosertib
14 Completed A New Prenatal Blood Test for Down Syndrome
Conditions: Down Syndrome;   Trisomy 21
Intervention:
15 Completed Pulmonary Hypertension in Trisomy 21 Patients
Condition: Congenital Disorders
Intervention:
16 Terminated Infant Weight Gain With Trisomy 21 and CAVC
Condition: Congenital Disorders
Intervention:
17 Completed Efficacy and Safety of ON 01910.Na in Myelodysplastic Syndrome (MDS) Patients With Trisomy 8 or Classified as Intermediate-1, -2 or High Risk
Condition: Myelodysplastic Syndrome
Intervention: Drug: ON 01910.Na
18 Recruiting Down Syndrome Metabolic Health Study
Conditions: Down Syndrome;   Trisomy 21
Intervention:
19 Completed Prenatal Test for Fetal Aneuploidy Detection
Conditions: Aneuploidy;   Trisomy 21
Intervention:
20 Enrolling by invitation Down Syndrome Screening Based on Dried Blood Spots and Cell-free Fetal DNA
Condition: Trisomy 21
Intervention: Procedure: cell-free fetal DNA

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years